| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/14737175.8.2.271 |
| P698 | PubMed publication ID | 18271712 |
| P2093 | author name string | Maria I Aguilar | |
| William D Freeman | |||
| P2860 | cites work | Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation | Q22305336 |
| Atrial fibrillation and stroke prevention | Q28165270 | ||
| Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? | Q28166299 | ||
| Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas | Q28176992 | ||
| A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke | Q28192128 | ||
| Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage | Q28192577 | ||
| Lessons from the Stroke Prevention in Atrial Fibrillation trials | Q28196151 | ||
| Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial | Q28209556 | ||
| Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation | Q28210235 | ||
| An association of prior statin use with decreased perihematomal edema | Q28219516 | ||
| Use of factor IX complex in warfarin-related intracranial hemorrhage | Q28375864 | ||
| Validation of Clinical Classification Schemes for Predicting Stroke | Q29028208 | ||
| Pathophysiology of brain edema formation | Q30756096 | ||
| Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study | Q31522746 | ||
| Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study | Q33183651 | ||
| Ongoing NovoSeven trials | Q33344984 | ||
| Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model | Q33591897 | ||
| Intracerebral haemorrhages and oral anticoagulation in the north of Scotland | Q34075223 | ||
| American Heart Association/American College of Cardiology Foundation guide to warfarin therapy | Q34196283 | ||
| Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: evidence-based support for an intensivist-directed specialty ICU model of care | Q34213451 | ||
| Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial | Q34306677 | ||
| Comparison of MRI and CT for detection of acute intracerebral hemorrhage | Q34360419 | ||
| Common VKORC1 and GGCX polymorphisms associated with warfarin dose | Q34417386 | ||
| Outcomes of neurocritical care | Q34566646 | ||
| Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation | Q34630189 | ||
| The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review | Q34976810 | ||
| Current management of intraventricular hemorrhage | Q35178788 | ||
| Clinical practice. Care of patients receiving long-term anticoagulant therapy. | Q35199069 | ||
| Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator | Q35483803 | ||
| Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study | Q35486572 | ||
| Stroke in a biracial population: the excess burden of stroke among blacks | Q35646518 | ||
| Novel therapies for intracerebral hemorrhage | Q35742572 | ||
| Critical care and emergency medicine neurology in stroke | Q36011192 | ||
| Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage | Q36065818 | ||
| Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements. | Q36206860 | ||
| Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline | Q36225992 | ||
| Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage | Q36256080 | ||
| The emerging role of recombinant-activated factor VII in neurocritical care | Q36262625 | ||
| Intracranial hemorrhage: the role of magnetic resonance imaging | Q36262632 | ||
| Thromboembolic adverse events after use of recombinant human coagulation factor VIIa | Q36371024 | ||
| Update on intracerebral haemorrhage | Q36471101 | ||
| Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care a | Q36810929 | ||
| Acute hypertension in intracerebral hemorrhage: pathophysiology and treatment | Q36841130 | ||
| Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review | Q36936577 | ||
| Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage | Q39737359 | ||
| Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. | Q39790576 | ||
| Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. | Q40458214 | ||
| Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage | Q40518629 | ||
| Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain | Q41721979 | ||
| Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies | Q42046164 | ||
| Risk factors for intracranial hemorrhage in outpatients taking warfarin | Q42285556 | ||
| Treatment of refractory intracranial hypertension with 23.4% saline | Q42457042 | ||
| The ICH score: a simple, reliable grading scale for intracerebral hemorrhage | Q43503411 | ||
| Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage | Q43660765 | ||
| Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage | Q43668447 | ||
| Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study | Q43787550 | ||
| Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). | Q43840992 | ||
| Warfarin therapy for atrial fibrillation in the elderly | Q43888383 | ||
| Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients | Q43889363 | ||
| The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings | Q44400710 | ||
| Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects | Q44507049 | ||
| National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation | Q44725124 | ||
| The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage | Q44865336 | ||
| Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage | Q45081496 | ||
| Spontaneous intracerebral hematomas from vascular causes. Predictive value of CT compared with angiography | Q45143837 | ||
| Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. | Q45184495 | ||
| Clinical experience with the use of clotting factor concentrates in oral anticoagulation reversal | Q45856224 | ||
| Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement | Q46276501 | ||
| Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation | Q46405965 | ||
| Introducing hypertonic saline for cerebral edema: an academic center experience | Q46713557 | ||
| Racial differences in the incidence of intracerebral hemorrhage: effects of blood pressure and education | Q46816106 | ||
| Systemic hemostasis with recombinant-activated factor VII followed by local thrombolysis with recombinant tissue plasminogen activator in intraventricular hemorrhage | Q46868201 | ||
| Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. | Q47269995 | ||
| Sedimentation level in acute intracerebral hematoma in a patient receiving anticoagulation therapy: an autopsy study | Q47743594 | ||
| Early edema in warfarin-related intracerebral hemorrhage | Q48093585 | ||
| Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage | Q48191305 | ||
| Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline | Q48218892 | ||
| Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage | Q48239118 | ||
| The increasing incidence of anticoagulant-associated intracerebral hemorrhage | Q48315722 | ||
| Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. | Q48397525 | ||
| Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage | Q48456034 | ||
| Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage | Q48456044 | ||
| Newly developed endoscopic instruments for the removal of intracerebral hematoma | Q48783574 | ||
| Early hemorrhage growth in patients with intracerebral hemorrhage | Q48821770 | ||
| An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation | Q48940645 | ||
| Treatment of intraventricular hemorrhage with urokinase : effects on 30-Day survival | Q49081771 | ||
| Temporal trends in the use of anticoagulants among older adults with atrial fibrillation. | Q50650041 | ||
| Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. | Q51081226 | ||
| Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. | Q53248535 | ||
| Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. | Q53532094 | ||
| Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. | Q53587853 | ||
| Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. | Q53624376 | ||
| The ABCs of measuring intracerebral hemorrhage volumes. | Q54430652 | ||
| Unexpected posthemorrhagic hydrocephalus in patients treated with rFVIIa | Q57756945 | ||
| Development of a Contemporary Bleeding Risk Model for Elderly Warfarin Recipients | Q58464315 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 271-290 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Management of warfarin-related intracerebral hemorrhage | |
| P478 | volume | 8 |
| Q82436763 | Does initial point of care influence neuro-ICU outcomes? |
| Q37580876 | Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis |
| Q53226046 | International normalised ratio normalisation in patients with coumarin-related intracranial haemorrhages--the INCH trial: a randomised controlled multicentre trial to compare safety and preliminary efficacy of fresh frozen plasma and prothrombin com |
| Q38113483 | Intracerebral hemorrhage in patients receiving oral anticoagulation therapy |
| Q36185368 | Postoperative anticoagulation in patients with mechanical heart valves following surgical treatment of subdural hematomas |
| Q36928194 | Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice |
| Q37788997 | Treatment of coagulopathy in intracranial hemorrhage |
| Q35121230 | Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: a structured literature review |
Search more.